Skip to content
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Menu
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Contact
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Menu
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Search
Close
Search
Close
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY
Menu
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY

Arbovirus

Diseases A-Z Index Arbovirus

Diseases A-Z Index:
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • W
  • V
  • X
  • Y
  • Z

What is Arbovirus?

More than a hundred arboviruses are known to cause human disease and are transmitted to humans by mosquitos, midges, sand flies and ticks. Endemic arboviral infections are most common in the late summer months when the temperatures are warmer and especially following periods of rainfall. Typically, mosquitoes, ticks and other vectors are more active during such times. Rift Valley fever-; West Nile-; Sindbis-; Chikungunya-  and Crimean-Congo haemorrhagic fever viruses are important arboviruses in South Africa, although other arboviruses are also found in South Africa.

Arboviral disease may be underdiagnosed and underreported in South Africa. Many arboviruses are not endemic to South Africa, but in the South African context are associated with travelers returning to South Africa from endemic areas. This includes, but is not limited to, dengue-; Zika and yellow fever viruses. Although chikungunya virus is endemic to South Africa, human cases in South Africa are usually travelers from other areas endemic for the virus.

Symptoms

The majority of arboviral infections are subclinical and self-resolving infections, but the disease spectrum is wide and disease may be debilitating and even fatal. Arboviral disease is broadly grouped according to four broad syndromes including fever, polyarthralgia, encephalitis and haemorrhagic fever, and a virus may be involved with more than one syndrome. Symptom onset can range from three to 14 days after the exposure.

Diagnosis, treatment and prevention

Specialised laboratory diagnostic investigation for arboviral diseases is required to confirm or exclude diagnosis. Typically, the viraemic phase of arbovirus infections are so short (may be prolonged in more severe cases) and negative RT-PCR results does not exclude the diagnosis of an arbovirus infection. Antibodies to arboviruses may be detected from day 3 – 7 after symptom onset. If initial antibody tests are negative, it is recommended to test a convalescent blood sample (collected two weeks after the acute phase of infection) to demonstrate seroconversion or the lack thereof. Laboratory findings should be considered in the light of the patient’s clinical findings and the possible exposure history.

Notifiable medical conditions

Rift Valley fever and Crimean-Congo haemorrhagic fever in humans are Category 1 notifiable medical conditions in South Africa. Other endemic, or non-endemic arboviral infections are listed as Category 3 notifiable medical conditions in the country.

Share

Share on facebook
Share on twitter
Arbovirus case investigation form (2021)
Facebook Instagram Linkedin Twitter Youtube

Quick Links

  • M&E Dashboard
  • Publications
  • Vacancies
  • Researcher Directory
  • Terms and Conditions

Download NMC

  • Android App
  • Huawei App
  • Web Portal
  • Apple App

Connect with our Researchers

Contact Us

© NICD 2021. All Rights Reserved
Disclaimer: The National Institute for Communicable Diseases does not provide Medical Advice to the public. For Medical Advice, please consult your Healthcare provider.